notificationsアラート設定
~
検索条件をクリア

アブストラクト

Title 10-1. MASLD/MASHの治療 : 食事運動療法をどう処方するか?
Subtitle 特集 MASLD/MASH - 脂肪性肝疾患の新概念 -
Authors 江口有一郎*1, 佐藤圭*2, 平川美智子*3, 原なぎさ*4, 高橋宏和*4
Authors (kana)
Organization *1医療法人ロコメディカルロコメディカル総合研究所, *2医療法人ロコメディカル江口病院リハビリテーション科, *3同栄養科, *4佐賀大学医学部附属病院肝疾患センター
Journal 肝臓クリニカルアップデート
Volume 10
Number 1
Page 71-78
Year/Month 2024 / 6
Article 報告
Publisher 医学図書出版
Abstract 「要旨」MASLD/MASHの多くは生活習慣の乱れが発症の基盤であり, 治療の大前提は食事運動療法である. 食事療法は, 低カロリー食や糖・脂質のエネルギー摂取比率の是正などが多くの症例に併存する生活習慣病への食事療法と併せて行われ, 運動療法は個々に合わせた有酸素運動およびレジスタンス運動が推奨されている. しかし生活習慣病である同疾患は行動変容の持続が不可欠であり, 適切な治療とフォローアップには, 多職種協働での取り組みをはじめ, これまでの肝疾患とは異なるアプローチが必要である.
Practice 臨床医学：内科系
Keywords 食事療法, 運動療法, 行動変容
  • 全文ダウンロード： 従量制、基本料金制の方共に1,023円(税込) です。
download全文ダウンロード(10.04MB)

参考文献

  • 1) 日本消化器病学会, 日本肝臓学会編 : NAFLD/NASH診療ガイドライン2020 改訂第2版. 南江堂, 2020
  • 2) Musso G, Cassader M, Rosina F, et al : Impact of current treatments on liver disease, glucose me-tabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD) : a systematic re-view and meta-analysis of randomised trials. Dia-betologia 55 : 885-904, 2012
  • 3) Tapper EB, Lai M : Weight loss results in signifi-cant improvements in quality of life for patients with nonalcoholic fatty liver disease : a prospec-tive cohort study. Hepatology 63 : 1184-1189, 2016
  • 4) Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al : Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149 : 367-378, 2015
  • 5) Fan JG, Kim SU, Wong VW : New trends on obe-sity and NAFLD in Asia. J Hepatol 67 : 862-873, 2017
残りの27件を表示する
  • 6) Li C, Guo P, Zhang R, et al : Both WHR and FLI as better algorithms for both lean and over-weight/obese NAFLD in a Chinese population. J Clin gastroenterol 53 : e253-260, 2019
  • 7) Wei JL, Leung JC, Loong TC, et al : Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients : a population study using proton-magnetic resonance spectroscopy. Am J Gastroenterol 110 : 1306-1314, 2015
  • 8) Younossi ZM, Stepanova M, Negro F, et al : Non-alcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 91 : 319-327, 2012
  • 9) Omagari K, Kadokawa Y, Masuda JI, et al : Fatty liver in non-alcoholic non-overweight Japanese adults : incidence and clinical characteristics. J Gastroenterol Hepatol 17 : 1098-1105, 2002
  • 10) Nishioji K, Sumida Y, Kamaguchi M, et al : Preva-lence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012. J Gastroenterol 50 : 95-108, 2015
  • 11) Wong VW, Wong GL, Chan RS, et al : Beneficial effects of lifestyle intervention in non-obese pa-tients with non-alcoholic fatty liver disease. J Hepatol 69 : 1349-1356, 2018
  • 12) Wang RT, Koretz RL, Yee HF Jr : Is weight re-duction an effective therapy for nonalcoholic fat-ty liver? A systematic review. Am J Med 115 : 554-559, 2003
  • 13) Haufe S, Engeli S, Kast P, et al : Randomized comparison of reduced fat and reduced carbohy-drate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatol-ogy 53 : 1504-1514, 2011
  • 14) Promrat K, Kleiner DE, Niemeier HM, et al : Ran-domized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hep-atology 51 : 121-129, 2010
  • 15) Vilar Gomez E, Rodriguez De Miranda A, Gra Oramas B, et al : Clinical trial : a nutritional sup-plement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 30 : 999-1009, 2009
  • 16) Wong VW, Chan RS, Wong GL, et al : Communi-ty-based lifestyle modification programme for non-alcoholic fatty liver disease : a randomized controlled trial. J Hepatol 59 : 536-542, 2013
  • 17) de Luis DA, Aller R, Izaola O, et al : Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver dis-ease and obese patients. Nutr Hosp 25 : 730-735, 2010
  • 18) Sacks FM, Bray GA, Carey VJ, et al : Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360 : 859-873, 2009
  • 19) Ryan MC, Itsiopoulos C, Thodis T, et al : The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-al-coholic fatty liver disease. J Hepatol 59 : 138-143, 2013
  • 20) Romero-Gomez M, Zelber-Sagi S, Trenell M : Treatment of NAFLD with diet, physical activi-ty and exercise. J Hepatol 67 : 829-846, 2017
  • 21) van der Heijden GJ, Wang ZJ, Chu ZD, et al : A 12-week aerobic exercise program reduces he-patic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring) 18 : 384-390, 2010
  • 22) Johnson NA, Sachinwalla T, Walton DW, et al : Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50 : 1105-1112, 2009
  • 23) Oh S, Shida T, Yamagishi K, et al : Moderate to vigorous physical activity volume is an impor-tant factor for managing nonalcoholic fatty liver disease : a retrospective study. Hepatology 61 : 1205-1215, 2015
  • 24) Katsagoni CN, Georgoulis M, Papatheodoridis GV, et al : Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fat-ty liver disease : a meta-analysis. Metabolism 68 : 119-132, 2017
  • 25) Hashida R, Kawaguchi T, Bekki M, et al : Aerobic vs. resistance exercise in non-alcoholic fatty liver disease : a systematic review. J Hepatol 66 : 142-152, 2017
  • 26) Orci LA, Gariani K, Oldani G, et al : Exercise-based interventions for nonalcoholic fatty liver disease : a meta-analysis and meta-regression. Clin Gastroenterol Hepatol 14 : 1398-1411, 2016
  • 27) 千葉県柏市オフィシャルウェブサイト. フレイルチェック : https://www.city.kashiwa.lg.jp/chikihokatsu/kaigo/yobo/frailcheck.html
  • 28) Oza N, Eguchi Y, Mizuta T et al : A pilot trial of body weight reduction for nonalcoholic fatty liv-er disease with a home-based lifestyle modifica-tion intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol 44 : 1203-1208, 2009
  • 29) Prochaska JO, Velicer WF : The transtheoretical model of health behavior change. Am J Health Promot 12 : 38-48, 1997
    pubmed
  • 30) 大竹文雄, 平井 啓 : 医療現場の行動経済学-すれ違う医者と患者. 東洋経済新報社, 2018
  • 31) 大竹文雄, 平井 啓 : 実践 医療現場の行動経済学-すれ違いの解消法. 東洋経済新報社, 2022
  • 32) Rinella ME, Lazarus JV, Ratziu V, et al : A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol 29 : 101133, 2024
はじめての方へ
個人／法人会員登録のご案内